Decrease of GABAergic markers and arc protein expression in the frontal cortex by intraventricular 192 IgG-saporin

Dementia and Geriatric Cognitive Disorders

Volumn 32, Issue 1, 2011, Pages 70-78

  Jeong, Da Un ^a   Chang, Won Seok ^a   Hwang, Yong Sup ^a,b   Lee, Dongkyu ^a   Chang, Jin Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b MI Tech Co Ltd   (South Korea)

Author keywords

Cholinergic systems; Glutamic acid decarboxylase; Immediate early gene; Medial forebrain bundle; Memory; Saporin

Indexed keywords

4 AMINOBUTYRIC ACID; ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; GLUTAMATE DECARBOXYLASE; SAPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; DEMENTIA; ELECTROSTIMULATION; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGENTS; CYTOSKELETAL PROTEINS; DEMENTIA; DISEASE MODELS, ANIMAL; FRONTAL LOBE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PARVALBUMINS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOME INACTIVATING PROTEINS, TYPE 1; SYNAPSES;

EID: 80052091356     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000330741     Document Type: Article

References (48)

1. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL: Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 1995;64:749-760.
2. Kasa P, Rakonczay Z, Gulya K: The cholinergic system in Alzheimer's disease. Prog Neurobiol 1997;52:511-535. (Pubitemid 27405078)
3. Toledano A, Alvarez MI: Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models. Curr A lzheimer Res 2004;1:189-214.
4. Baxter MG, Chiba AA: Cognitive functions of the basal forebrain. Curr Opin Neurobiol 1999;9:178-183. (Pubitemid 29201789)
5. Wiley RG, Oeltmann TN, Lappi DA: Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Bra in Res 1991;562:149-153.
6. Book AA, Wiley RG, Schweitzer JB: 192 IgG-saporin. 1. Specific lethality for cholinergic neurons in the basal forebrain of the rat. J Neuropathol Exp Neurol 1994;53:95-102.
7. Book AA, Wiley RG, Schweitzer JB: Specificity of 192 IgG-saporin for NGF receptor-positive cholinergic basal forebrain neurons in t he rat. Brain Res 1992;590:350-355.
8. Rossner S, Schliebs R, Perez-Polo JR, Wiley RG, Bigl V: Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. J Neurosci Res 1995;40:31-43.
9. Frick KM, Kim JJ, Baxter MG: Effects of complete immunotoxin lesions of the cholinergic basal forebrain on fear conditioning and spatial learning. Hippocampus 2004;14:244-254. (Pubitemid 38477110)
10. Van der Zee EA, Luiten PG: Cholinergic and GABAergic neurons in the rat medial septum express muscarinic acetylcholine receptors. Brain Res 1994;652:263-272. (Pubitemid 24227281)
11. Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG: Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 1994;14:5986-5995. (Pubitemid 24307792)
12. Frielingsdorf H, Thal LJ, Pizzo DP: The septohippocampal cholinergic system and spatial working memory in the Morris water maze. Behav Brain Res 2006;168:37-46. (Pubitemid 43152051)
13. Vuckovich JA, Semel ME, Baxter MG: Extensive lesions of cholinergic basal forebrain neurons do not impair spatial working memory. Learn Mem 2004;11:87-94. (Pubitemid 38167062)
14. Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ: 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience 1995;65:463-476.
15. Walsh TJ, Kelly RM, Dougherty KD, Stackman RW, Wiley RG, Kutscher CL: Behavioral and neurobiological alterations induced by the immunotoxin 192-IgG-saporin: cholinergic and non-cholinergic effects following icv Injection. Brain Res 1995;702:233-245.
16. Nilsson OG, Leanza G, Rosenblad C, Lappi DA, Wiley RG, Bjorklund A: Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. Neuroreport 1992;3:1005-1008.
17. Severino M, Pedersen AF, Trajkovska V, Christensen E, Lohals R, Veng LM, Knudsen GM, Aznar S: Selective immunolesion of cholinergic neurons leads to long-term changes in 5-HT2A receptor levels in hippocampus and frontal cortex. Neurosci Lett 2007;428:47-51. (Pubitemid 47633802)
18. Leanza G, Nilsson OG, Wiley RG, Bjorklund A: Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur J Neurosci 1995;7:329-343.
19. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 6. San Diego, Elsevier Academic Press, 2007.
20. Gu Z, Yu J, Perez-Polo JR: Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion. Brain Res 1998;801:190-197. (Pubitemid 28401663)
21. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
22. Moreau PH, Cosquer B, Jeltsch H, Cassel JC, Mathis C: Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus 2008;18:610-622. (Pubitemid 351832748)
23. McCormick DA, Prince DA: Mechanisms of action of acetylcholine in the guinea-pig cerebral cortex in vitro. J Physiol 1986;375:169-194. (Pubitemid 16097603)
24. Behrends JC, ten Bruggencate G: Cholinergic modulation of synaptic inhibition in the guinea pig hippocampus in vitro: excitation of GABAergic interneurons and inhibition of GABA-release. J Neurophysiol 1993;69:626-629. (Pubitemid 23064321)
25. Jouvenceau A, Billard JM, Lamour Y, Dutar P: Potentiation of glutamatergic EPSPs in rat CA1 hippocampal neurons after selective cholinergic denervation by 192 IgG-saporin. Synapse 1997;26:292-300. (Pubitemid 27240745)
26. Garcia-Alloza M, Zaldua N, Diez-Ariza M, Marcos B, Lasheras B, Javier Gil-Bea F, Ramirez MJ: Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory. J Neuropathol Exp Neurol 2006;65:1074-1081. (Pubitemid 44684665)
27. Reisine TD, Yamamura HI, Bird ED, Spokes E, Enna SJ: Pre-and postsynaptic neurochemical alterations in Alzheimer's disease. Brain Res 1978;159:477-481. (Pubitemid 9095276)
28. Lanctot KL, Herrmann N, Mazzotta P, Khan LR, Ingber N: GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can J Psychiatry 2004;49:439-453. (Pubitemid 39071365)
29. Lloyd GK, Lowenthal A, Javoy-Agid F, Constantidinis J: GABAA receptor complex function in frontal cortex membranes from control and neurological patients. Eur J Pha rmacol 1991;197:33-39.
30. Satoh J, Tabira T, Sano M, Nakayama H, Tateishi J: Parvalbumin- immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease. Acta Neuropathol 1991;81:388-395.
31. Ferrer I, Soriano E, Tunon T, Fonseca M, Guionnet N: Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J Neurol Sci 1991;106:135-141.
32. Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH: Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 1991;50:451-462.
33. Ferrer I, Zujar MJ, Rivera R, Soria M, Vidal A, Casas R: Parvalbumin-immunoreactive dystrophic neurites and aberrant sprouts in the cerebral cortex of patients with Alzheimer's disease. Neurosci Lett 1993;158:163-166. (Pubitemid 23255479)
34. Dwyer TA, Servatius RJ, Pang KC: Noncholinergic lesions of the medial septum impair sequential learning of different spatial locations. J Neurosci 2007;27:299-303. (Pubitemid 46106002)
35. Constantinidis C, Williams GV, Goldman-Rakic PS: A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 2002;5:175-180. (Pubitemid 34121586)
36. Kohl MM, Paulsen O: The roles of GABAB receptors in cortical network activity. Adv Pharmacol 2010;58:205-229.
37. Fell J, Klaver P, Lehnertz K, Grunwald T, Schaller C, Elger CE, Fernandez G: Human memory formation is accompanied by rhinal-hippocampal coupling and decoupling. Nat Neurosci 2001;4:1259-1264. (Pubitemid 33135633)
38. Sederberg PB, Schulze-Bonhage A, Madsen JR, Bromfield EB, McCarthy DC, Brandt A, Tully MS, Kahana MJ: Hippocampal and neocortical gamma oscillations predict memory formation in humans. Cereb Cortex 2007;17:1190-1196. (Pubitemid 46598861)
39. Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, Mao X, Engelsberg A, Mahlke C, Welzl H, Kobalz U, Stawrakakis A, Fernandez E, Waltereit R, Bick-Sander A, Therstappen E, Cooke SF, Blanquet V, Wurst W, Salmen B, Bosl MR, Lipp HP, Grant SG, Bliss TV, Wolfer DP, Kuhl D: Arc/arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 2006;52:437-444. (Pubitemid 44755254)
40. Steward O, Wallace CS, Lyford GL, Worley PF: Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 1998;21:741-751. (Pubitemid 28498783)
41. Matzel LD, Kolata S: Selective attention, working memory, and animal intelligence. Neurosci Biobehav Rev 2010;34:23-30.
42. Smith EE, Jonides J: Storage and executive processes in the frontal lobes. Science 1999;283:1657-1661.
43. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA: Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance oflong-term potentiation and the consolidation oflongterm memory. J Neurosci 2000;20:3993-4001. (Pubitemid 30365669)
44. Sjobeck M, Englund E: Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes. Dement Geriatr Cogn Disord 2001;12:211-218. (Pubitemid 32217851)
45. Fukutani Y, Cairns NJ, Rossor MN, Lantos PL: Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzhei mer's disease. Neurosci Lett 1996;214:33-36. (Pubitemid 26273982)
46. Gandhi CC, Kelly RM, Wiley RG, Walsh TJ: Impaired acquisition of a Morris water maze task following selective destruction of cerebellar Purkinje cells with OX7-saporin. Behav Brain Res 2000;109:37-47. (Pubitemid 30107872)
47. Martin LA, Escher T, Goldowitz D, Mittleman G: A relationship between cerebellar Purkinje cells and spatial working memory demonstrated in a lurcher/chimera mouse model system. Genes Brain Behav 2004;3:158-166. (Pubitemid 38715464)
48. Baillieux H, De Smet HJ, Paquier PF, De Deyn PP, Marien P: Cerebellar neurocognition: insights into the bottom of the brain. Clin Neurol Neurosurg 2008;110:763-773.